S&P Futures
3,882.00-16.75(-0.43%)Dow Futures
31,392.00-117.00(-0.37%)Nasdaq Futures
13,229.50-50.25(-0.38%)
Moderna, Inc. (MRNA)
Chart Events
Performance Outlook
| Previous Close | 154.81 |
| Open | 154.46 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's Range | 145.25 - 157.75 |
| 52 Week Range | 19.31 - 189.26 |
| Volume | 15,351,555 |
| Avg. Volume | 19,876,618 |
| Market Cap | 62.285B |
| Beta (5Y Monthly) | 1.50 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.96 |
| Earnings Date | May 05, 2021 - May 10, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 168.92 |
Fair Value
Related Research
- Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
- Weekly Stock List
- Editor's PickYahoo Finance Video
Novavax CEO on COVID-19 vaccine trial progress
Novavax CEO Stanley Erck joined Yahoo Finance Live to discuss the company's COVID-19 vaccine trial progress and his business outlook for the company.
- Editor's PickYahoo Finance Video
J&J to roll-out single-shot COVID-19 vaccine this week
Johnson & Johnson’s single-shot coronavirus vaccine wins FDA approval. Yahoo FInance’s Anjalee Khemlani breaks down the details.
- Reuters
UPDATE 1-Fauci says U.S. must stick to two-shot strategy for Pfizer, Moderna COVID-19 vaccines - paper
The United States must stick to a two-dose strategy for the Pfizer-BioNTech and Moderna COVID-19 vaccines, top U.S. infectious disease official Anthony Fauci told the Washington Post newspaper. Fauci said that delaying a second dose to inoculate more Americans creates risks. He warned that shifting to a single-dose strategy for the vaccines could leave people less protected, enable variants to spread and possibly boost skepticism among Americans already hesitant to get the shots.
